Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Controlled ovarian hyperstimulation

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    32 result(s) found for: Controlled ovarian hyperstimulation. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2008-000201-11 Sponsor Protocol Number: VLC-CB-090108-001 Start Date*: 2008-05-30
    Sponsor Name:Instituto Valenciano de Infertilidad
    Full Title: Ensayo piloto randomizado, doble-ciego, en grupos paralelos, placebo-controlado, monocéntrico evaluando la tolerabilidad de la quinagolida 200mcg/día en un régimen de aumento de dosis en donantes d...
    Medical condition: Pacientes con riesgo del Sindrome de Hiperestimulación Ovárica (SHO)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10033266 Ovarian hyperstimulation syndrome LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-000415-15 Sponsor Protocol Number: FE 999051 CS01 Start Date*: 2006-05-25
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: EQUIPO (Efecto de Quinagolida en la Prevención de OHSS) Estudio de prueba de hipótesis, aleatorizado, doble ciego, de grupos paralelos, en búsqueda de dosis, controlado con placebo, multicéntrico,...
    Medical condition: Síndrome de hiperestimulación ovárica en mujeres con hiperestimulación ovárica controlada en técnicas de reproducción asistida
    Disease: Version SOC Term Classification Code Term Level
    8.1 10033266 PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2018-003484-56 Sponsor Protocol Number: BOLDOS-18 Start Date*: 2019-12-26
    Sponsor Name:Miguel Caballero Campo
    Full Title: Efficacy of corifolitropin alfa in double ovarian stimulation compared with two conventional ovarian stimulation cycles for embryo accmulation in low responder patients. Multicenter randomized cont...
    Medical condition: Infertility in patients requiring in vitro fertilization treatment with poor ovarian response profile, defined by Bologna Criteria.
    Disease: Version SOC Term Classification Code Term Level
    21.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-002341-30 Sponsor Protocol Number: 1705-VLC-030-JG Start Date*: 2017-09-11
    Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDAD (IVI)
    Full Title: Usefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors to prevent premature luteinization
    Medical condition: prevent premature luteinitation
    Disease: Version SOC Term Classification Code Term Level
    20.0 10041244 - Social circumstances 10072070 Oocyte donor PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2005-000993-29 Sponsor Protocol Number: 04I/HMG10 Start Date*: 2005-07-19
    Sponsor Name:IBSA
    Full Title: A prospective, randomized, investigator-blind, controlled, clinical study of phase III on the clinical efficacy and tolerability of hMG-IBSA IBSA Institut Biochimique sa versus Menopur Ferring ...
    Medical condition: COH Controlled Ovarian Hyperstimulation in ART Assisted Reproductive Technology /IVF
    Disease: Version SOC Term Classification Code Term Level
    6.1 10056204 PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-001503-36 Sponsor Protocol Number: PROT25186 Start Date*: 2004-11-03
    Sponsor Name:SERONO ESPAÑA, S.A.
    Full Title: Lutropin alfa (Luveris) in mid follicular phase for controlled ovarian stimulation (COS) in ovarian ageing: a randomised, comparative with parallel control group, phase II clinical trial.
    Medical condition: Controlled ovarian stimulation in women with ovarian ageing PT: Assisted Fertilisation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10003539 PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2005-000500-13 Sponsor Protocol Number: 8821 Start Date*: 2005-08-15
    Sponsor Name:University of Oxford- Research Services
    Full Title: Metformin treatment before IVF in women with ultrasound evidence of polycystic ovaries; a prospective, randomised, double blind, placebo controlled study
    Medical condition: Infertile women undergoing IVF with sonographic evidence of polycystic ovaries but without any clinical manifestations of polycystic ovarian syndrome.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-004532-10 Sponsor Protocol Number: POI-1 Start Date*: 2018-05-23
    Sponsor Name:Karolinska University Hospital
    Full Title: Effects of immunomodulatory therapy on gonadal function in women with autoimmune premature ovarian insufficiency
    Medical condition: Autoimmune premature ovarian insufficiency
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004860 10052660 Hypergonadotropic hypogonadism LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing) NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-003481-34 Sponsor Protocol Number: indvFSH2006 Start Date*: 2006-08-04
    Sponsor Name:Fertilitetsklinikken 4071, Rigshospitalet
    Full Title: Individuel versus standard rFSH dosis til kontrolleret ovariel stimulation og intrauterin insemination Et prospektivt randomiseret multicenter studie
    Medical condition: Ovulatory women suffering from infertility
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-004684-58 Sponsor Protocol Number: FE 200486 CS24 Start Date*: 2007-01-08
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, assessor-blind, parallel groups, multi-centre, exploratory study assessing the impact of subcutaneous administration of degarelix 2.5 mg on synchronisation of follicle cohort compared...
    Medical condition: Prevention of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation for assisted reproductive technologies (ART)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10021926 Infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed) CZ (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-012323-29 Sponsor Protocol Number: FE200440CS11 Start Date*: 2009-12-22
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, double-blind, parallel groups, placebo-controlled, multi-centre trial in oocyte donors assessing the effects of barusiban, a selective oxytocin antagonist, on uterine contractions on ...
    Medical condition: Co-adjuvant therapy in the luteal phase to prevent embryo expulsion and facilitate implantation and pregnancy in women undergoing assisted reproductive technologies (i.e. IVF/ICSI with embryo trans...
    Disease: Version SOC Term Classification Code Term Level
    12.0 10061400 Uterine contractions abnormal LLT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Completed) ES (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2005-002229-30 Sponsor Protocol Number: 26170 Start Date*: 2005-09-19
    Sponsor Name:Serono España, S.A.
    Full Title: Lutropin alfa in mid follicular phase in women at risk of poor response suppresed with cetrorelix: an exploratory trial.Lutropina alfa en mitad de la fase folicular en mujeres con riesgo de pobre r...
    Medical condition: Controlled ovarian stimulation in assisted fertilisation. PT: assisted Fertilisation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10003539 PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2015-003856-31 Sponsor Protocol Number: BER-LUT-2015-02 Start Date*: 2015-12-04
    Sponsor Name:INSTITUTO BERNABEU
    Full Title: EARLY FOLLICULAR PHASE vs LUTHEAL PHASE OVARIAN STIMULATION IN BOLOGNA CRITERIA IVF/ICSI CYCLES: A RANDOMIZED COMPARATIVE SINGLE CENTER TRIAL. LUTEAL TRIAL
    Medical condition: Patients with diagnosis of low response (Bologna criteria) and who perform ovarian stimulation for accumulation of vitrified oocytes.
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004872 10016398 Female infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-002482-19 Sponsor Protocol Number: 13EU/FSH01 Start Date*: 2013-12-12
    Sponsor Name:IBSA Institut Biochimique S.A.
    Full Title: Randomised clinical trial comparing highly purified FSH formulation (Fostimon®) and recombinant FSH (Gonal-F®) in GnRH-antagonist controlled ovarian hyperstimulation cycles.
    Medical condition: female infertility
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004872 10016398 Female infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed) GB (Completed) ES (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2014-005331-14 Sponsor Protocol Number: 1411-MAD-079-CB Start Date*: 2015-08-19
    Sponsor Name:IVI Madrid
    Full Title: A prospective randomized trial to analyze the effect of the gonadotropin administered during controlled ovarian stimulation on embryo kinetics of development
    Medical condition: The study is proposed to analyze the effect of three types of gonadotropin on embryo quality and kinetics of development in women undergoing an assisted reporduction treatment
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-006775-67 Sponsor Protocol Number: FE 999906 CS08 Start Date*: 2009-04-29
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, open-label, assessor-blind, parallel groups, multicentre trial compating the efficacy of MENOPUR versus recombinant FSH in controlled ovarian stimulation following a GnRH antagonist p...
    Medical condition: Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021926 Infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed) SE (Completed) ES (Completed) CZ (Completed) PL (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2016-005208-24 Sponsor Protocol Number: hCG-GR-001-2016 Start Date*: 2017-07-12
    Sponsor Name:Prof. Harry Siristatidis
    Full Title: A prospective, multicenter, double-blind, randomized, placebo-controlled, two-parallel groups Phase IIIb clinical study, to assess the efficacy and safety of adding low doses of hCG at a short IVF ...
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10021928 Infertility female PT
    Population Age: Adults Gender: Female
    Trial protocol: GR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-004114-99 Sponsor Protocol Number: FERTIRES-2016 Start Date*: 2017-05-18
    Sponsor Name:AB-BIOTICS
    Full Title: USE OF P.N680S POLYMORPHISM TO CHOOSE THE EXOGEN FSH DOSE IN CONTROLLED OVARIAN HYPERSTIMULATION: A PROSPECTIVE TRIAL
    Medical condition: Infertility
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-001743-20 Sponsor Protocol Number: 1403-MAD-013-AR Start Date*: 2015-07-30
    Sponsor Name:IVI Madrid
    Full Title: A Multicentre, prospective, randomised clinical trial comparing the cost and efficacy of corifolitropina alfa vs Recombinant FSH and / or HP-hMG
    Medical condition: The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-004545-91 Sponsor Protocol Number: 59874 Start Date*: 2017-04-13
    Sponsor Name:VU University Medical Center, department of reproductive Medicine
    Full Title: Continuous use of Oral contraceptives as an alternative for long term Pituitary down-regulation with GnRH agonist prior to IVF/ICSI in Endometriosis patients: a randomised controlled trial (COPIE t...
    Medical condition: The research population consists of women with surgically confirmed endometriosis ASRM stage III or IV or endometrioma on transvaginal ultrasound or MRI, scheduled for an IVF/ICSI treatment.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 19 11:19:25 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA